Risklick
1 known investors
Find your way into Risklick
Sign up to see every warm intro you have to Risklick
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Risklick team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
RiskLick develops Protocol AI, an AI-powered software platform for designing and developing clinical trial protocols and study plans to accelerate drug development timelines. The platform serves pharmaceutical companies and clinical research organizations seeking to reduce time to market and improve protocol quality.
Founders & leadership
S

Sven
B

Beat
I

IngridPhysician
Board
ME

Matthias EggerProfessor of Epidemiology
Investors · 1
Frequently asked questions
- What does Risklick do?
- RiskLick develops Protocol AI, an AI-powered software platform for designing and developing clinical trial protocols and study plans to accelerate drug development timelines. The platform serves pharmaceutical companies and clinical research organizations seeking to reduce time to market and improve protocol quality.
- Who are Risklick's investors?
- Risklick's investors include Debiopharm Innovation Fund.
